X

MDT

Medtronic PLC (MDT) Medtronic receives FDA clearance for Stealth AXiS™ surgical system, first integrated planning, navigation and robotics platform for spine surgery

Medtronic PLC (NYSE: MDT) FY 2026 Other Release

Medtronic PLC (MDT) Q3 2026 Earnings Results

Medtronic PLC (NYSE: MDT) Q3 2026 Earnings Release

Medtronic PLC (MDT) Q1 2026 Earnings Call Transcript

Medtronic PLC (NYSE: MDT) Q1 2026 Earnings Call dated Aug. 19, 2025 Corporate Participants: Ryan Weispfenning — Vice President and…

Medtronic PLC (MDT) Q2 2025 Earnings Call Transcript

Medtronic PLC (NYSE: MDT) Q2 2025 Earnings Call dated Nov. 19, 2024 Corporate Participants: Ryan Weispfenning — Vice President and…

Medtronic PLC (MDT) Q3 2025 Earnings Call Transcript

Medtronic PLC (NYSE: MDT) Q3 2025 Earnings Call dated Feb. 18, 2025 Corporate Participants: Ryan Weispfenning — Vice President &…

Medtronic PLC (MDT) Q4 2025 Earnings Call Transcript

Medtronic PLC (NYSE: MDT) Q4 2025 Earnings Call dated May. 21, 2025 Corporate Participants: Ryan Weispfenning — Vice President and…

Medtronic (MDT) reports higher revenue and profit for Q1 2025

Medical device maker Medtronic plc (NYSE: MDT) reported an increase in revenues and adjusted profit for the first quarter of…

Key metrics from Medtronic’s (MDT) Q4 2024 earnings results

Medtronic plc (NYSE: MDT) reported fourth quarter 2024 earnings results today. Worldwide revenue was $8.6 billion, up 0.5% on a…

Medtronic (MDT) Q3 2024 revenue rises 5%; adj. earnings flat

Medical device maker Medtronic plc (NYSE: MDT) reported an increase in revenues for the third quarter of 2024 when the…

Medtronic (MDT) Q2 2024 adj. earnings decline despite revenue growth

Medical device maker Medtronic plc (NYSE: MDT) reported a decline in adjusted earnings for the second quarter of 2024, despite…